Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sucampo/Takeda’s Amitiza Gains IBS-C Indication

Related Content

Novartis Further Restricts Access To Zelnorm

Apr 03 2008

Takeda/Sucampo To Launch Constipation Agent Amitiza In Early Second Quarter

Jan 31 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window